Comtan 200 mg Oral Tablet
RxNorm 261318
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 261318 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Comtan 200 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
PSNPrescribable
Prescribable Name (PSN):
Comtan 200 mg Oral Tablet
(Atom ID: 6364382)
SYPrescribable
Synonym (SY):
Comtan 200 mg Oral Tablet
(Atom ID: 1312180)
SBDPrescribable
Semantic Branded Drug (SBD):
Entacapone 200 mg Oral Tablet [Comtan]
(Atom ID: 1312179)
Patient Education
Entacapone
Entacapone is an inhibitor of catechol-O-methyltransferase (COMT). It is used in combination with levodopa and carbidopa (Sinemet) to treat the end-of-dose 'wearing-off' symptoms of Parkinson's disease. Entacapone helps the levodopa and carbidopa work better by allowing more of it to reach the brain, where it has its effects. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
[Learn More]
* Please review the disclaimer below.